Order Now, Ships Today
One-time
Optional add-on for reconstitution workflow.
| Quantity | Discount | Discounted price |
| 3 - 4 | 5% | $40.80 |
| 5 - 6 | 7% | $39.94 |
| 7 - 8 | 9% | $39.08 |
| 9 + | 11% | $38.23 |
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist used experimentally to investigate MC3R and MC4R signaling. Research applications include receptor activation, neural signaling, vascular-response mechanisms and melanocortin pathway characterization.
This research peptide is verified for 99%+ purity. COA: PT-141 (10mg)
Products from Elite Miami Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Each vial contains the quantity of lyophilized research material indicated on the product label. Refer to the lot-specific Certificate of Analysis for identity and purity information.
Yes. All peptides are supplied in lyophilized powder form and do not come reconstituted. Any extra materials required for research, such as solvents or diluents, must be obtained separately.
When stored as a dry powder, peptides remain stable for up to 2 years.
Once reconstituted, the solution should be kept refrigerated and is typically stable for up to 2 months under proper storage conditions.
PT-141 is a synthetic peptide designed to target the melanocortin system, a network of receptors involved in energy regulation, neural signaling, and stress response. In laboratory environments, it has been used to explore neural activation, cardiovascular dynamics, and receptor-specific modulation without directly affecting melanogenesis (skin pigmentation).
PT-141 is a peptide studied for its interaction with melanocortin receptors in the central nervous system. It works through the melanocortin system rather than hormone or blood-flow pathways. Researchers use it to understand how these receptors influence neural signaling, energy balance, and stress signaling in laboratory models.
⚠️ Disclaimer: this product is not approved for medical use and is not intended to diagnose, treat, or prevent any disease. All information provided is for educational and research purposes only, and this product must never be used in humans or animals.
PT-141 was developed through research into melanocortin peptides, originally derived from modifications of Melanotan II. While Melanotan II was primarily studied for its pigment-inducing properties, PT-141 was synthesized to focus on central melanocortin receptor activity. Since its discovery, PT-141 has been investigated in models of neuroendocrine function, vascular regulation, and receptor-mediated signaling. Shadiack A.M. et al. (2002).
CAS #: 189691-06-3 Molecular Formula: C₅₀H₆₈N₁₄O₁₀ Molecular Weight: 1025.2 g/mol PubChem ID: 6918280
PT-141 has been evaluated for its effects on neurovascular and receptor activity in preclinical studies. Key areas include: Neurological: activation of central melanocortin receptors (MC3R and MC4R). Behavioral: modulation of stress-response mechanisms in experimental models. Vascular: investigation into receptor-driven blood flow and circulation. Systemic: influence on the hypothalamic-pituitary axis and hormonal signaling. These findings highlight PT-141’s research potential in studying neuroendocrine and receptor-mediated systems.
In simple terms, PT-141 is a lab-engineered peptide that interacts with receptors in the brain related to energy and stress signaling. Researchers study it to understand how these brain pathways influence physiological responses in laboratory models. However, PT-141 is not approved for human or animal use — it is meant solely for scientific research and laboratory testing.
Wessells H., et al. (2003). Central melanocortin pathways and receptor activation. Shadiack A.M., et al. (2002). PT-141 as a selective MC4R agonist: preclinical evaluation. Dorr R.T., et al. (1996). Pharmacological characterization of melanocortin analogs. Hadley M.E., et al. (1998). The melanocortin system: structure, receptors, and biological roles.
Cerebrolysin
PE-22-28
Our specialists respond within minutes to any order or product inquiry.
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
All compounds from Elite Miami Peptides are intended strictly for laboratory research purposes.
They are not for human use, consumption, or therapeutic applications.
Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.
